In turn, the downregulation of miR-184 has been associated with obesity-related inflammation, insulin secretion, and resistance through aberrant PKCβ and AKT2 signalling [63–65]. The gene discussed is AKT2; the disease is obesity due to melanocortin 4 receptor deficiency.